A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-Tumor Ability in Human Cancer Cells in Vitro and in Vivo

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00205
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Correction: A Novel Compound NSC745885 Exerts an Anti-Tumor Effect on Tongue Cancer SAS Cells in Vitro and in Vivo

PLoS ONE
Multidisciplinary
2014English

MLN8054, an Inhibitor of Aurora a Kinase, Induces Senescence in Human Tumor Cells Both in Vitro and in Vivo

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells

Scientific Reports
Multidisciplinary
2016English

Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and Is Synergistic With Trastuzumab in Vitro and in Vivo

Clinical Cancer Research
Cancer ResearchOncology
2010English

In Vitro and in Vivo Activity of a New Small-Molecule Inhibitor of HDAC6 in Mantle Cell Lymphoma

Haematologica
Hematology
2018English

Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo

Cellular Physiology and Biochemistry
Physiology
2019English

A Novel Taspine Derivative Suppresses Human Liver Tumor Growth and Invasion in Vitro and in Vivo

Oncology Letters
Cancer ResearchOncology
2013English

Tumor Necrosis Factor Increases the Production of Plasminogen Activator Inhibitor in Human Endothelial Cells in Vitro and in Rats in Vivo

1987English

A Designed Peptide Targeting CXCR4 Displays Anti-Acute Myelocytic Leukemia Activity in Vitro and in Vivo

Scientific Reports
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy